is retatrutide fda approved yet Retatrutide's TRIUMPH-1 result explains why people care: Lilly reported 28.3% mean body-weight loss at 80 weeks on 12 mg, and 45.3% losing at least 30%. But the more interesting story the ⚠️ BEWARE OF RETATRUTIDE SOLD

If Phase 3 confirms the Phase 2 numbers, retatrutide would represent a significant step beyond the current gold standard, not just an incremental improvement

GLP-1R: glucagon-like peptide-1 receptor

Resistance Training: We require our patients to engage in at least 23 sessions of strength training per week

Side effects: Similarities and potential differences Weight loss patches currently available are not GLP-1 mimetics, and may not have the same side effects as GLP-1 drugs, like Wegovy, Ozempic, Mounjaro, or Zepbound

In recent years, GLP-1 therapy has become a transformative treatment option for individuals managing Type 2 diabetes and obesity

HbA1c Reductions Across Follow-Up Overall, the average follow-up duration was 5.8 months, with longer follow-up times in body weight (8.2 months) and HbA1c cohorts (8.1 months